The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


PAGLITAZ

15 Milligram Tablets

Krka d.d., Novo mestoEU/1/11/721/001-007

Main Information

Trade NamePAGLITAZ
Active SubstancesPIOGLITAZONE HYDROCHLORIDE
Strength15 Milligram
Dosage FormTablets
Licence HolderKrka d.d., Novo mesto
Licence NumberEU/1/11/721/001-007

Group Information

ATC CodeA10BG03 pioglitazone

Status

Authorised/WithdrawnAuthorised
Licence Issued21/03/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back